Literature DB >> 4646504

Cell-mediated immunity in patients positive for hepatitis-associated antigen.

F J Dudley, V Giustino, S Sherlock.   

Abstract

Cell-mediated immunity to antigens prepared from both serum and liver of patients positive for hepatitis-associated antigen (H.A.A.) was measured by using the leucocyte migration test. Altogether, 43 patients with H.A.A.-positive acute and chronic liver disease, eight with serum antibody to H.A.A., and 13 controls were studied. The cell-mediated immunity detected was specific for H.A.A. or other antigenic determinants of the associated infective agent and could be found only in patients with evidence of previous contact with H.A.A.Cell-mediated immunity to the H.A.A.-positive test antigens was found in all but one of the patients with acute hepatitis, in about half of the patients with chronic aggressive hepatitis or cirrhosis, rarely in those with chronic persistent hepatitis, and in none of the apparently healthy carriers.Our results support the hypothesis that the cellular immune response plays an important part in the clearance of the infective agent from H.A.A.-positive patients and in the pathogenesis of the associated liver cell injury.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4646504      PMCID: PMC1786998          DOI: 10.1136/bmj.4.5843.754

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  9 in total

1.  Cellular immunity and hepatitis-associated, Australia antigen liver disease.

Authors:  F J Dudley; R A Fox; S Sherlock
Journal:  Lancet       Date:  1972-04-01       Impact factor: 79.321

2.  Viral hepatitis. New light on an old disease.

Authors:  S Krugman; J P Giles
Journal:  JAMA       Date:  1970-05-11       Impact factor: 56.272

3.  Hepatitis-associated antigen in chronic liver disease.

Authors:  R A Fox; S P Niazi; S Sherlock
Journal:  Lancet       Date:  1969-09-20       Impact factor: 79.321

Review 4.  A leucocyte migration technique for in vitro detection of cellular (delayed type) hypersensitivity in man.

Authors:  G Bendixen; M Soborg
Journal:  Dan Med Bull       Date:  1969-01

5.  Chronic hepatitis--migration inhibition of leukocytes in the presence of Australia antigen.

Authors:  K Ito; J Nakagawa; Y Okimoto; H Nakano
Journal:  N Engl J Med       Date:  1972-05-04       Impact factor: 91.245

6.  Relation of Australia-SH antigen to the willowbrook MS-2 strain.

Authors:  J P Giles; R W McCollum; L W Berndtson; S Krugman
Journal:  N Engl J Med       Date:  1969-07-17       Impact factor: 91.245

7.  In citro migration of peripheral human leucocytes in cellular hypersensitivity.

Authors:  M Soborg
Journal:  Acta Med Scand       Date:  1968 Jul-Aug

8.  Rapid detection of Australia antigen by counterimmunoelectrophoresis.

Authors:  D J Gocke; C Howe
Journal:  J Immunol       Date:  1970-04       Impact factor: 5.422

9.  Human lymphocyte migration as a parameter of hypersensitivity.

Authors:  M Soborg; G Bendixen
Journal:  Acta Med Scand       Date:  1967-02
  9 in total
  47 in total

Review 1.  Immunologic reactivity and alcoholic liver disease.

Authors:  R K Zetterman; C M Leevy
Journal:  Bull N Y Acad Med       Date:  1975-04

Review 2.  Immunological reactivity and viral hepatitis.

Authors:  S Sherlock
Journal:  Bull N Y Acad Med       Date:  1975-04

3.  ad and ay subtypes of hepatitis B antigen in a case of hypogammaglobulinaemia.

Authors:  J W Lawton; R Hopkins; I C Paterson; P C Das
Journal:  J Clin Pathol       Date:  1975-11       Impact factor: 3.411

4.  Cell-mediated immunity in guinea pigs to subunits derived from hepatitis B surface antigen.

Authors:  G A Cabral; R Chairez; F Marciano-Cabral; M Suarez; G R Dreesman; J L Melnick; F B Hollinger
Journal:  Infect Immun       Date:  1975-09       Impact factor: 3.441

Review 5.  Viral hepatitis.

Authors:  J Y Lau; G J Alexander; A Alberti
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

6.  Immune response to hepatitis B surface antigen.

Authors:  A B Ibrahim; G N Vyas; H A Perkins
Journal:  Infect Immun       Date:  1975-01       Impact factor: 3.441

7.  T-lymphocytes and hepatitis B serology.

Authors:  E Kaklamani; D Trichopoulos; G Papaevangelou; M Drouga; D Karalis; G Papoutsakis
Journal:  Infection       Date:  1978       Impact factor: 3.553

8.  Cell-mediated immune response in primary biliary cirrhosis to a protein fraction from human bile.

Authors:  A L Eddleston; I G McFarlane; C G Mitchell; W D Reed; R Williams
Journal:  Br Med J       Date:  1973-11-03

9.  Influence of (+)-cyanidanol-3 on the leukocyte migration inhibition test carried out in the presence of purified protein derivative and hepatitis B surface antigen.

Authors:  J J Vallotton; P C Frei
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

10.  Patterns of chronic liver disease in Kuwait with special reference to localisation of hepatitis B surface antigen.

Authors:  M S Al Adnani; S M Ali
Journal:  J Clin Pathol       Date:  1984-05       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.